ImmunoPrecise Antibodies Ltd. (IPA)
$4.62-7.04%Close
SELLCRISIS · day 1
Key stats
- Market cap
- $213M
- Beta
- 0.49
- P/E (TTM)
- -8.15
- 1W
- -7.41%
- 1M
- -11.83%
- vs SPY 1W
- -8.58%
- vs SPY 1M
- -14.82%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IPA?
- LOPJLB’s latest quantitative signal on ImmunoPrecise Antibodies Ltd. (IPA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IPA in?
- ImmunoPrecise Antibodies Ltd. (IPA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does ImmunoPrecise Antibodies Ltd. (IPA) do?
- ImmunoPrecise Antibodies Ltd. (IPA) is a global biotechnology firm that, through its subsidiaries, focuses on the development and production of antibodies, alongside offering a broad spectrum of related scientific services. Its operational footprint spans across the United States, Canada, Europe, Australia, and other international territories. For the research community, IPA delivers a diverse …